Funding-In Vivo Nanoplatforms for Diagnostics (IVN:Dx); June 28, 2012

Agency

DARPA - Microsystems Technology Office

Description

The specific objective of the In vivo Nanoplatforms for Diagnostics (IVN:Dx) thrust of the In vivo Nanoplatforms (IVN) program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. These sensors will permit qualitative and quantitative assessment over large concentration ranges of both small (e.g., glucose, lactate, and urea) and large molecules (e.g., proteins, oligonucleotides, infectious agents, and chemical/biological threat agents) in the organism and environment through optical, electronic, thermal or magnetic mechanisms. See full DARPA-BAA-12-33 attached.

Announcement Number: DARPA-BAA-12-33

Closing Date: Jun 28, 2012   

Link to Full Announcement

http://www.darpa.mil/Opportunities/Solicitations/MTO_Solicitations.aspx

Contact Information

Dr. Timothy Broderick
Program Manager MTO BAA Coordinator